Dr. Chunlan Pu is an Assistant Researcher and Master’s Supervisor at Southwest Jiaotong University, specializing in Medicinal Chemistry. Her research primarily focuses on targeted protein degradation strategies, including PROTAC (proteolysis-targeting chimera) technology, the development of chemical probes for anticancer targets, and combinational drug therapies. She is particularly dedicated to the discovery of novel therapeutics for treatment-refractory cancers such as triple-negative breast cancer and pancreatic cancer.
Dr. Pu has led five research projects funded by various provincial and municipal agencies, including the Sichuan Provincial Department of Science and Technology, the Health Commission of Sichuan Province, and the Chengdu Science and Technology Bureau, in addition to two institution-level grants. She has also played key roles in several national and regional research programs. To date, she has published over ten SCI-indexed papers as the first or corresponding author in peer-reviewed journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Chinese Chemical Letters, and Bioorganic Chemistry, with an H-index of 14.
Dr. Chunlan Pu is an Assistant Researcher and Master’s Supervisor at Southwest Jiaotong University, specializing in Medicinal Chemistry. Her research primarily focuses on targeted protein degradation strategies, including PROTAC (proteolysis-targeting chimera) technology, the development of chemical probes for anticancer targets, and combinational drug therapies. She is particularly dedicated to the discovery of novel therapeutics for treatment-refractory cancers such as triple-negative breast cancer and pancreatic cancer.
Dr. Pu has led five research projects funded by various provincial and municipal agencies, including the Sichuan Provincial Department of Science and Technology, the Health Commission of Sichuan Province, and the Chengdu Science and Technology Bureau, in addition to two institution-level grants. She has also played key roles in several national and regional research programs. To date, she has published over ten SCI-indexed papers as the first or corresponding author in peer-reviewed journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Chinese Chemical Letters, and Bioorganic Chemistry, with an H-index of 14.